Nectin-4 Expression Is an Independent Prognostic Biomarker and Associated With Better Survival in Triple-Negative Breast Cancer

Frontiers in Medicine - Switzerland
doi 10.3389/fmed.2019.00200
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

Frontiers Media SA

Related search

The WNT10B Network Is Associated With Survival and Metastases in Chemoresistant Triple-Negative Breast Cancer

Cancer Research
Cancer ResearchOncology
2018English

miR‑320a Is an Independent Prognostic Biomarker for Invasive Breast Cancer

Oncology Letters
Cancer ResearchOncology
2014English

HAGE in Triple-Negative Breast Cancer Is a Novel Prognostic, Predictive, and Actionable Biomarker: A Transcriptomic and Protein Expression Analysis

Clinical Cancer Research
Cancer ResearchOncology
2015English

Prognostic Role of GPER/Ezrin in Triple Negative Breast Cancer Is Associated With Menopausal Status

Endocrine Connections
Internal MedicineEndocrinologyMetabolismDiabetes
2019English

Prognostic Value of ERBB4 Expression in Patients With Triple Negative Breast Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2016English

Mesothelin Expression and Survival Outcomes in Triple Receptor Negative Breast Cancer

Clinical Breast Cancer
Cancer ResearchOncology
2013English

Nottingham Prognostic Index Is an Applicable Prognostic Tool in Non-Metastatic Triple-Negative Breast Cancer

Asian Pacific Journal of Cancer Prevention
2019English

T‑cadherin Is Associated With Prognosis in Triple‑negative Breast Cancer

Oncology Letters
Cancer ResearchOncology
2017English

MicroRNA-138 Is a Prognostic Biomarker for Triple-Negative Breast Cancer and Promotes Tumorigenesis via TUSC2 Repression

Scientific Reports
Multidisciplinary
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy